{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"rhabdomyolysis-myalgia","columns":[{"gene":"","key":"population-0a6c67085444d366201f","label":"rhabdomyolysis-myalgia syndrome","mondoId":"MONDO:0850415","onsetQualifier":null,"originColumnKey":"MONDO:0850415/no-native-evidence","originalViews":[{"key":"MONDO:0850415/no-native-evidence","label":"rhabdomyolysis-myalgia syndrome","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0a6c67085444d366201f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-0a6c67085444d366201f"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A myopathy that is characterized by muscle breakdown (rhabdomyolysis), heat and exertion-related muscle pain (myalgia) and cramping symptoms, severe muscle pain, sudden elevation and subsequent fall of serum creatine phosphokinase levels and products of muscle breakdown in the urine (myoglobinuria). Associated with RYR1 variations. Rhabdomyolysis is associated with a range of external triggers, including strenuous exercise beyond the limit of fatigue, heat stress, illicit drug or alcohol abuse, use of supplements or certain medications, recent viral illness or muscle trauma.","mondoId":"MONDO:0850415","node":{"canonicalSlug":"rhabdomyolysis-myalgia","comparisons":[{"documentSha256":"b1e5f7f43e8f49e0bbae4bc040d5fcaf71a0f64cfc31b221de852ff97503d7cd","key":"expanded-ryr1-related-myopathy","kind":"expanded","label":"RYR1-related myopathy","memberIds":["MONDO:0007294","MONDO:0009712","MONDO:0018528","MONDO:0020485","MONDO:0100150","MONDO:0850415"],"mondoId":"MONDO:0100150","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-b1e5f7f43e8f49e0bbae.b1e5f7f43e8f49e0bbae4bc040d5fcaf71a0f64cfc31b221de852ff97503d7cd.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"rhabdomyolysis-myalgia syndrome","paragraphs":["A myopathy that is characterized by muscle breakdown (rhabdomyolysis), heat and exertion-related muscle pain (myalgia) and cramping symptoms, severe muscle pain, sudden elevation and subsequent fall of serum creatine phosphokinase levels and products of muscle breakdown in the urine (myoglobinuria). Associated with RYR1 variations. Rhabdomyolysis is associated with a range of external triggers, including strenuous exercise beyond the limit of fatigue, heat stress, illicit drug or alcohol abuse, use of supplements or certain medications, recent viral illness or muscle trauma."],"scope":"exact","source":"MONDO","upstream":"DOID:0080992","url":"https://monarchinitiative.org/MONDO:0850415"},"ownColumnKeys":["population-0a6c67085444d366201f"],"publication":"published","relationships":[{"kind":"parent","label":"RYR1-related myopathy","mondoId":"MONDO:0100150","slug":"ryr1-related-myopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26612"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0850415\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0080992</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A myopathy that is characterized by muscle breakdown (rhabdomyolysis), heat and exertion-related muscle pain (myalgia) and cramping symptoms, severe muscle pain, sudden elevation and subsequent fall of serum creatine phosphokinase levels and products of muscle breakdown in the urine (myoglobinuria). Associated with RYR1 variations. Rhabdomyolysis is associated with a range of external triggers, including strenuous exercise beyond the limit of fatigue, heat stress, illicit drug or alcohol abuse, use of supplements or certain medications, recent viral illness or muscle trauma.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0850415\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"rhabdomyolysis-myalgia","sourceDocuments":[{"name":"MONDO: rhabdomyolysis-myalgia syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0850415"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"rhabdomyolysis-myalgia syndrome"},"schemaVersion":1}
